SCHEMBL8876991

SCHEMBL8876991

Cc1nc(Nc2ccccc2)n(C)c(=O)c1CCN1CC2CC(c3ccc(F)cc3)C2C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 0.37
▸ CYP2D6 P10635 3/20 0.37
▸ TSHR P16473 3/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ HTR1A P08908 2/20 0.37
▸ PKM P14618 2/20 0.37
▸ HTR2C P28335 2/20 0.37
▸ PMP22 Q01453 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ THPO P40225 1/20 0.37
▸ ACHE P22303 3/20 0.36
▸ LMNA P02545 3/20 0.35
▸ ALOX15 P16050 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ TP53 P04637 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8879255 0.91 P2RX3 (0.37) MAPTTSHRCYP3A4LMNAALDH1A1
SCHEMBL8804858 0.89 CYP2D6 (0.36) MAPTCYP2D6TSHRMEN1KMT2A
SCHEMBL8877427 0.88 MAPT (0.40) MAPTCYP2D6TSHRMEN1KMT2A
SCHEMBL8804087 0.87 TSHR (0.35) MAPTCYP2D6TSHRMEN1KMT2A
SCHEMBL8877896 0.86 KAT2B (0.33) MAPTCYP2D6TSHRSMN1; SMN2KDM4E
SCHEMBL8877192 0.86 GRIN2B (0.36) KMT2ASMN1; SMN2KDM4ECYP3A4LMNA
SCHEMBL8878777 0.85 MAPT (0.35) MAPTCYP2D6TSHRMEN1KMT2A
SCHEMBL8807137 0.85 SMN1; SMN2 (0.36) MAPTCYP2D6TSHRMEN1KMT2A
SCHEMBL8878126 0.83 TSHR (0.37) MAPTCYP2D6TSHRMEN1KMT2A
SCHEMBL8806120 0.83 CYP2D6 (0.36) MAPTCYP2D6TSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616705-A N-substituted azabicycloheptane derivatives, their preparation and use BASF AKTIENGESELLSCHAFT (DE) 1997-04-01 — — US disclosed
EP-0740658-A1 N-SUBSTITUTED AZABICYCLOHEPTANE DERIVATIVES USED, FOR EXAMPLE, AS NEUROLEPTICS BASF AKTIENGESELLSCHAFT (DE) 1996-11-06 — — EP disclosed
WO-1995015312-A1 N-SUBSTITUTED AZABICYCLOHEPTANE DERIVATIVES USED, FOR EXAMPLE, AS NEUROLEPTICS BASF AKTIENGESELLSCHAFT (DE) 1995-06-08 — — WO disclosed
Send feedback